医療用大麻市場レポート：種属、誘導体、用途、最終用途、投与経路、地域別、2024年～2032年

世界の医療用大麻市場規模は2023年に344億米ドルに達しました。今後、IMARC Groupは、2024年から2032年にかけて7.4%の成長率（CAGR）を示し、2032年までに667億米ドルに達すると予測しています。薬物使用障害の治療における製品使用の増加、慢性炎症症状に対する製品の探求、胃腸障害に対する製品需要の高まり、CBDベースの製品に対する需要の高まりは、市場を推進する要因の一部です。

医療用大麻は医療用マリファナとしても知られ、カンナビス・サティバ種またはカンナビス・インディカ種由来の植物性医薬品です。テトラヒドロカンナビノール（THC）やカンナビジオール（CBD）などのカンナビノイドを含み、体内のエンドカンナビノイド系と相互作用して治療効果をもたらします。慢性疼痛、てんかん、多発性硬化症、化学療法による吐き気など、さまざまな病状の緩和や管理に可能性が示されています。医療用大麻の使用は多くの国や州で合法化されているが、厳格な規制と医師の処方が必要です。医療用大麻の研究は成長を続けており、様々な健康状態の治療におけるその有効性を探求しています。

世界市場の主な原動力となっているのは、医療目的での同製品の受け入れ拡大です。これに伴い、医療用大麻の合法化の拡大が市場に大きく寄与しています。さらに、同製品の潜在的な治療効果に対する認識の高まりが、市場にプラスの影響を与えています。これとは別に、大麻研究と医学研究の急速な進歩は、市場に多くの機会を提供しています。さらに、大麻製品で治療可能な慢性疼痛やその他の病状の有病率の増加が市場を活性化しています。加えて、高齢化人口の増加により、加齢に伴う疾患の代替治療法を求める人々が増えていることも、市場を後押ししています。オピオイド危機と、より安全な疼痛管理オプションの模索が市場を強化しています。さらに、天然素材や植物由来の医薬品に対する需要の高まりが市場を後押ししています。

医療用大麻市場の動向と促進要因：

臨床試験の増加、研究開発（R&D）活動、大麻ベースの適応症の商業化

臨床試験の増加、研究開発（R&D）活動、大麻ベースの適応症の商業化が市場を促進しています。受容の拡大と合法化に伴い、研究者、製薬会社、医療関係者の間で、この製品の潜在的な治療効果を探求する関心が高まっています。臨床試験と調査研究は、さまざまな病状に対する大麻ベースの治療法の有効性と安全性を裏付ける科学的証拠を提供するために不可欠です。このような研究からより肯定的な結果が出るにつれて、正当な治療選択肢としての医療用大麻に対する信頼が高まり、より広い範囲での採用につながります。さらに、大麻ベースの適応症の商業化には、製薬会社や新興企業から多額の投資が行われています。標準化された大麻ベースの医薬品の開発は、より一貫した投与、品質管理、規制遵守を提供し、ヘルスケア業界における製品の正当性をさらに高めています。大麻製品が主流医療にしっかりと組み込まれるにつれ、市場は拡大し、より多くの患者、ヘルスケアプロバイダー、投資家を惹きつけることが期待されます。このような研究開発・商業化の積極的な機運が市場を活性化します。

消費者の可処分所得の増加

消費者の可処分所得の増加は、市場に好影響を与えています。可処分所得が増加するにつれて、消費者は代替・補完治療を含むヘルスケアに費やす経済力を持つようになります。購買力が高まることで、個人は様々な健康状態のために製品を検討し、投資する可能性が高まる。医療用大麻は、地域によっては保険が適用されないこともあるが、可処分所得の高い消費者にとっては現実的な選択肢となりうる。可処分所得の増大は、消費者の嗜好がよりホリスティックで自然な健康療法へとシフトすることにも寄与します。個人の健康が優先されるにつれて、伝統的な医薬品以外の代替療法を求めるようになり、製品需要の増加につながります。加えて、可処分所得が増加することで、消費者はより高品質で評判の高い供給元からの製品を購入できるようになり、市場のプレミアム・セグメントを後押ししています。

新しい大麻ベースの医薬品の出現

新しい大麻ベースの医薬品の出現が市場を強化しています。カンナビノイドやその他の大麻由来化合物の治療可能性を探る研究や臨床試験が続く中、製薬会社は革新的な大麻ベースの医薬品を開発しています。これらの新医薬品は厳格な試験を経て規制当局の承認を得ており、その安全性と有効性について医療従事者や患者に信頼感を与えています。その結果、より多くのヘルスケアプロバイダーが様々な病状に対して大麻ベースの医薬品を処方することに前向きとなり、市場導入が促進されています。標準化された大麻ベースの医薬品が開発されたことで、投与量の一貫性や品質管理に関する懸念も解消され、信頼性が高まり、患者やヘルスケア提供者にとって魅力的なものとなった。さらに、新しい大麻ベースの医薬品の出現は、慢性疼痛や神経疾患から精神的な病気に至るまで、幅広い症状の治療における医療用大麻の潜在的な用途を拡大します。

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査目的
• 利害関係者
• データソース
  • 一次情報
  • 二次情報
• 市場推定
  • ボトムアップアプローチ
  • トップダウンアプローチ
• 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

• 概要
• 主要産業動向

第5章 世界の医療用大麻市場

• 市場概要
• 市場実績
• COVID-19の影響
• 市場内訳：種属別
• 市場内訳：誘導体別
• 市場内訳：用途別
• 市場内訳：最終用途別
• 市場内訳：投与経路別
• 市場内訳：地域別
• 市場予測
• SWOT分析
  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威
• バリューチェーン分析
  • インプット・サプライヤー
  • コレクター
  • 製造業者
  • 流通業者
  • 輸出業者
  • 小売業者
  • エンドユーザー
• ポーターのファイブフォース分析
  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威
• 主な成功要因とリスク要因

第6章 市場内訳：種属別

• インディカ
  • 市場動向
  • 市場予測
• サティバ
  • 市場動向
  • 市場予測
• ハイブリッド
  • 市場動向
  • 市場予測

第7章 市場内訳：誘導体別

• カンナビジオール（CBD）
  • 市場動向
  • 市場予測
• テトラヒドロカンナビノール（THC）
  • 市場動向
  • 市場予測
• その他
  • 市場動向
  • 市場予測

第8章 市場内訳：用途別

• がん
  • 市場動向
  • 市場予測
• 関節炎
  • 市場動向
  • 市場予測
• 片頭痛
  • 市場動向
  • 市場予測
• てんかん
  • 市場動向
  • 市場予測
• その他
  • 市場動向
  • 市場予測

第9章 市場内訳：最終用途別

• 医薬品産業
  • 市場動向
  • 市場予測
• 研究開発センター
  • 市場動向
  • 市場予測
• その他
  • 市場動向
  • 市場予測

第10章 市場内訳：投与経路別

• 経口剤、カプセル剤
  • 市場動向
  • 市場予測
• 気化器
  • 市場動向
  • 市場予測
• 外用
  • 市場動向
  • 市場予測
• その他
  • 市場動向
  • 市場予測

第11章 市場内訳：地域別

• 北米
  • 米国
    • 市場動向
    • 市場予測
  • カナダ
    • 市場動向
    • 市場予測
• 欧州
  • ドイツ
    • 市場動向
    • 市場予測
  • イタリア
    • 市場動向
    • 市場予測
  • フランス
    • 市場動向
    • 市場予測
  • オランダ
    • 市場動向
    • 市場予測
  • スペイン
    • 市場動向
    • 市場予測
• ラテンアメリカ
  • 市場動向
  • 市場予測
• アジア太平洋
  • 市場動向
  • 市場予測
• 中東・アフリカ地域
  • 市場動向
  • 市場予測

第12章 様々な適応症における医療用大麻の有用性を示唆する臨床研究の概要

• アルツハイマー病
• 自閉症
• がん
• 慢性疼痛
• てんかん
• 片頭痛
• 消化器疾患
• 多発性硬化症
• 統合失調症
• その他

第13章 競合情勢

• 市場構造
• 主要企業

第14章 主要プレーヤーのプロファイル

• Canopy Growth Corporation
• GW Pharmaceuticals, plc
• Aurora Cannabis, Inc.
• Aphria, Inc.
• MedReleaf Corporation
• Insys Therapeutics, Inc.
• CanniMed Therapeutics, Inc.
• Cara Therapeutics, Inc.
• United Cannabis Corporation

List of Figures

• Figure 1: Global: Medical Cannabis Market: Major Drivers and Challenges
• Figure 2: Global: Medical Cannabis Market: Value Trends (in Billion US$), 2018-2023
• Figure 3: Global: Medical Cannabis Market: Breakup by Species (in %), 2023
• Figure 4: Global: Medical Cannabis Market: Breakup by Derivatives (in %), 2023
• Figure 5: Global: Medical Cannabis Market: Breakup by Application (in %), 2023
• Figure 6: Global: Medical Cannabis Market: Breakup by End-Use (in %), 2023
• Figure 7: Global: Medical Cannabis Market: Breakup by Route of Administration (in %), 2023
• Figure 8: Global: Medical Cannabis Market: Breakup by Region (in %), 2023
• Figure 9: Global: Medical Cannabis Market Forecast: Value Trends (in Billion US$), 2024-2032
• Figure 10: Global: Medical Cannabis Industry: SWOT Analysis
• Figure 11: Global: Medical Cannabis Industry: Value Chain Analysis
• Figure 12: Global: Medical Cannabis Industry: Porter's Five Forces Analysis
• Figure 13: Global: Medical Cannabis Market (Indica): Value Trends (in Million US$), 2018 & 2023
• Figure 14: Global: Medical Cannabis Market Forecast (Indica): Value Trends (in Million US$), 2024-2032
• Figure 15: Global: Medical Cannabis Market (Sativa): Value Trends (in Million US$), 2018 & 2023
• Figure 16: Global: Medical Cannabis Market Forecast (Sativa): Value Trends (in Million US$), 2024-2032
• Figure 17: Global: Medical Cannabis Market (Hybrid): Value Trends (in Million US$), 2018 & 2023
• Figure 18: Global: Medical Cannabis Market Forecast (Hybrid): Value Trends (in Million US$), 2024-2032
• Figure 19: Global: Medical Cannabis Market (Cannabidiol-CBD): Value Trends (in Million US$), 2018 & 2023
• Figure 20: Global: Medical Cannabis Market Forecast (Cannabidiol-CBD): Value Trends (in Million US$), 2024-2032
• Figure 21: Global: Medical Cannabis Market (Tetrahydrocannabinol-THC): Value Trends (in Million US$), 2018 & 2023
• Figure 22: Global: Medical Cannabis Market Forecast (Tetrahydrocannabinol-THC): Value Trends (in Million US$), 2024-2032
• Figure 23: Global: Medical Cannabis Market (Other Derivatives): Value Trends (in Million US$), 2018 & 2023
• Figure 24: Global: Medical Cannabis Market Forecast (Other Derivatives): Value Trends (in Million US$), 2024-2032
• Figure 25: Global: Medical Cannabis Market (Application in Cancer): Value Trends (in Million US$), 2018 & 2023
• Figure 26: Global: Medical Cannabis Market Forecast (Application in Cancer): Value Trends (in Million US$), 2024-2032
• Figure 27: Global: Medical Cannabis Market (Application in Arthritis): Value Trends (in Million US$), 2018 & 2023
• Figure 28: Global: Medical Cannabis Market Forecast (Application in Arthritis): Value Trends (in Million US$), 2024-2032
• Figure 29: Global: Medical Cannabis Market (Application in Migraine): Value Trends (in Million US$), 2018 & 2023
• Figure 30: Global: Medical Cannabis Market Forecast (Application in Migraine): Value Trends (in Million US$), 2024-2032
• Figure 31: Global: Medical Cannabis Market (Application in Epilepsy): Value Trends (in Million US$), 2018 & 2023
• Figure 32: Global: Medical Cannabis Market Forecast (Application in Epilepsy): Value Trends (in Million US$), 2024-2032
• Figure 33: Global: Medical Cannabis Market (Other Applications): Value Trends (in Million US$), 2018 & 2023
• Figure 34: Global: Medical Cannabis Market Forecast (Other Applications): Value Trends (in Million US$), 2024-2032
• Figure 35: Global: Medical Cannabis Market (End-Use in Pharmaceutical Industry): Value Trends (in Million US$), 2018 & 2023
• Figure 36: Global: Medical Cannabis Market Forecast (End-Use in Pharmaceutical Industry): Value Trends (in Million US$), 2024-2032
• Figure 37: Global: Medical Cannabis Market (End-Use in Research and Development Centres): Value Trends (in Million US$), 2018 & 2023
• Figure 38: Global: Medical Cannabis Market Forecast (End-Use in Research and Development Centres): Value Trends (in Million US$), 2024-2032
• Figure 39: Global: Medical Cannabis Market (Other End-Uses): Value Trends (in Million US$), 2018 & 2023
• Figure 40: Global: Medical Cannabis Market Forecast (Other End-Uses): Value Trends (in Million US$), 2024-2032
• Figure 41: Global: Medical Cannabis Market (Administration through Oral Solutions and Capsules): Value Trends (in Million US$), 2018 & 2023
• Figure 42: Global: Medical Cannabis Market Forecast (Administration through Oral Solutions and Capsules): Value Trends (in Million US$), 2024-2032
• Figure 43: Global: Medical Cannabis Market (Administration through Vaporizers): Value Trends (in Million US$), 2018 & 2023
• Figure 44: Global: Medical Cannabis Market Forecast (Administration through Vaporizers): Value Trends (in Million US$), 2024-2032
• Figure 45: Global: Medical Cannabis Market (Administration through Topicals): Value Trends (in Million US$), 2018 & 2023
• Figure 46: Global: Medical Cannabis Market Forecast (Administration through Topicals): Value Trends (in Million US$), 2024-2032
• Figure 47: Global: Medical Cannabis Market (Other Route of Administrations): Value Trends (in Million US$), 2018 & 2023
• Figure 48: Global: Medical Cannabis Market Forecast (Other Route of Administrations): Value Trends (in Million US$), 2024-2032
• Figure 49: North America: Medical Cannabis Market: Value Trends (in Million US$), 2018 & 2023
• Figure 50: North America: Medical Cannabis Market Forecast: Value Trends (in Million US$), 2024-2032
• Figure 51: United States: Medical Cannabis Market: Value Trends (in Million US$), 2018 & 2023
• Figure 52: United States: Medical Cannabis Market Forecast: Value Trends (in Million US$), 2024-2032
• Figure 53: Canada: Medical Cannabis Market: Value Trends (in Million US$), 2018 & 2023
• Figure 54: Canada: Medical Cannabis Market Forecast: Value Trends (in Million US$), 2024-2032
• Figure 55: Europe: Medical Cannabis Market: Value Trends (in Million US$), 2018 & 2023
• Figure 56: Europe: Medical Cannabis Market Forecast: Value Trends (in Million US$), 2024-2032
• Figure 57: Germany: Medical Cannabis Market: Value Trends (in Million US$), 2018 & 2023
• Figure 58: Germany: Medical Cannabis Market Forecast: Value Trends (in Million US$), 2024-2032
• Figure 59: Italy: Medical Cannabis Market: Value Trends (in Million US$), 2018 & 2023
• Figure 60: Italy: Medical Cannabis Market Forecast: Value Trends (in Million US$), 2024-2032
• Figure 61: France: Medical Cannabis Market: Value Trends (in Million US$), 2018 & 2023
• Figure 62: France: Medical Cannabis Market Forecast: Value Trends (in Million US$), 2024-2032
• Figure 63: Netherlands: Medical Cannabis Market: Value Trends (in Million US$), 2018 & 2023
• Figure 64: Netherlands: Medical Cannabis Market Forecast: Value Trends (in Million US$), 2024-2032
• Figure 65: Spain: Medical Cannabis Market: Value Trends (in Million US$), 2018 & 2023
• Figure 66: Spain: Medical Cannabis Market Forecast: Value Trends (in Million US$), 2024-2032
• Figure 67: Latin America: Medical Cannabis Market: Value Trends (in Million US$), 2018 & 2023
• Figure 68: Latin America: Medical Cannabis Market Forecast: Value Trends (in Million US$), 2024-2032
• Figure 69: Asia Pacific: Medical Cannabis Market: Value Trends (in Million US$), 2018 & 2023
• Figure 70: Asia Pacific: Medical Cannabis Market Forecast: Value Trends (in Million US$), 2024-2032
• Figure 71: Middle East and Africa: Medical Cannabis Market: Value Trends (in Million US$), 2018 & 2023
• Figure 72: Middle East and Africa: Medical Cannabis Market Forecast: Value Trends (in Million US$), 2024-2032

List of Tables

• Table 1: Global: Medical Cannabis Market: Key Industry Highlights, 2023 and 2032
• Table 2: Global: Medical Cannabis Market Forecast: Breakup by Species (in Million US$), 2024-2032
• Table 3: Global: Medical Cannabis Market Forecast: Breakup by Derivatives (in Million US$), 2024-2032
• Table 4: Global: Medical Cannabis Market Forecast: Breakup by Application (in Million US$), 2024-2032
• Table 5: Global: Medical Cannabis Market Forecast: Breakup by End-Use (in Million US$), 2024-2032
• Table 6: Global: Medical Cannabis Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
• Table 7: Global: Medical Cannabis Market Forecast: Breakup by Region (in Million US$), 2024-2032
• Table 8: Global: Medical Cannabis Market: Competitive Structure
• Table 9: Global: Medical Cannabis Market: Key Players

Abstract

The global medical cannabis market size reached US$ 34.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 66.7 Billion by 2032, exhibiting a growth rate (CAGR) of 7.4% during 2024-2032. The increasing product use in treating substance use disorders, the exploration of products for chronic inflammatory conditions, the rising product demand for gastrointestinal disorders, and the rising demand for CBD-based products are some of the factors propelling the market.

Medical cannabis, also known as medical marijuana, is a plant-based medicine derived from the Cannabis sativa or Cannabis indica species. It contains cannabinoids, including tetrahydrocannabinol (THC) and cannabidiol (CBD), which interact with the body's endocannabinoid system to produce therapeutic effects. It has shown potential in alleviating symptoms and managing various medical conditions, including chronic pain, epilepsy, multiple sclerosis, and nausea caused by chemotherapy. Its medicinal use has been legalized in many countries and states, subject to strict regulations and medical prescriptions. Research on medical cannabis continues to grow, exploring its efficacy in treating various health conditions.

The global market is majorly driven by the increasing acceptance of the product for medicinal purposes. In line with this, the expanding legalization of the product is significantly contributing to the market. Furthermore, the rising awareness of the potential therapeutic benefits of the product is positively influencing the market. Apart from this, the rapid advancements in cannabis research and medical studies are offering numerous opportunities for the market. Moreover, the growing prevalence of chronic pain and other medical conditions treatable with the product is catalyzing the market. Besides, the escalating aging population seeking alternative treatments for age-related ailments is propelling the market. The opioid crisis and the search for safer pain management options are bolstering the market. Additionally, the increasing demand for natural and plant-based medicines is providing a boost to the market.

Medical Cannabis Market Trends/Drivers:

Rising clinical trials, research and development (R&D) activities, and commercialization of cannabis-based indications

The rising clinical trials, research and development (R&D) activities, and commercialization of cannabis-based indications are fostering the market. With increasing acceptance and legalization, there is a growing interest among researchers, pharmaceutical companies, and medical professionals to explore the potential therapeutic benefits of the product. Clinical trials and research studies are essential to provide scientific evidence supporting the efficacy and safety of cannabis-based treatments for various medical conditions. As more positive results emerge from these studies, confidence in medical cannabis as a legitimate treatment options increases, leading to wider adoption. Furthermore, commercializing cannabis-based indications has seen substantial investments from pharmaceutical companies and startups. The development of standardized cannabis-based pharmaceutical products offers more consistent dosing, quality control, and regulatory compliance, further legitimizing the product in the healthcare industry. As the product becomes more firmly integrated into mainstream medicine, the market is expected to expand, attracting more patients, healthcare providers, and investors. This positive momentum in research, development, and commercialization fuels the market.

Inflating disposable incomes of the consumers

The inflating disposable incomes of the consumers are favorably impacting the market. As disposable incomes rise, consumers have more financial capacity to spend on healthcare, including alternative and complementary treatments. With increased purchasing power, individuals are more likely to explore and invest in the product for various health conditions. Medical cannabis, which may not be covered by insurance in some regions, can become a viable option for consumers with higher disposable incomes. Inflating disposable incomes also contribute to a shift in consumer preferences towards more holistic and natural health remedies. As individuals prioritize their well-being, they seek alternative treatments beyond traditional pharmaceuticals, leading to increased demand for the product. Additionally, higher disposable incomes allow consumers to afford these products that may be of higher quality or from reputable sources, boosting the premium segment of the market.

The emergence of new cannabis-based pharmaceutical products

The emergence of new cannabis-based pharmaceutical products is bolstering the market. As research and clinical trials continue to explore the therapeutic potential of cannabinoids and other cannabis-derived compounds, pharmaceutical companies are developing innovative cannabis-based medications. These new pharmaceutical products undergo rigorous testing and regulatory approvals, instilling confidence in medical professionals and patients about their safety and efficacy. As a result, more healthcare providers are open to prescribing cannabis-based medications for various medical conditions, thus driving market adoption. The development of standardized cannabis-based pharmaceuticals also addresses concerns about dosage consistency and quality control, making them more reliable and appealing to patients and healthcare providers. Moreover, the emergence of new cannabis-based medications expands the potential applications of medical cannabis in treating a wide range of conditions, from chronic pain and neurological disorders to mental health ailments.

Medical Cannabis Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global medical cannabis market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on species, derivatives, application, end-use and route of administration.

Breakup by Species:

Indica

Sativa

Hybrid

Indica dominates the market

The report has provided a detailed breakup and analysis of the market based on the species. This includes indica, sativa, and hybrid. According to the report, indica represented the largest segment.

As one of the primary cannabis species, Cannabis indica is known for its high CBD content and relatively lower THC levels compared to Cannabis sativa. The increased interest in CBD-based products and therapeutic applications has boosted the demand for Cannabis indica strains. CBD is recognized for its potential benefits in managing various health conditions, such as pain, anxiety, and inflammation, without inducing the psychoactive effects commonly associated with THC.

Moreover, Indica's relaxing and sedative properties make it appealing for medicinal use in addressing sleep disorders and promoting relaxation. As consumers seek natural alternatives to traditional medications, Cannabis indica is increasingly sought after as a potential treatment option. The evolving legal landscape and greater acceptance of medical cannabis have also contributed to the market growth of Cannabis indica products. With the increasing number of states and countries legalizing medical cannabis, indica strains are gaining traction among patients and healthcare professionals, propelling market expansion further.

Breakup by Derivatives:

Cannabidiol (CBD)

Tetrahydrocannabinol (THC)

Others

Tetrahydrocannabinol (THC) dominates the market

The report has provided a detailed breakup and analysis of the market based on the derivatives. This includes cannabidiol (CBD), tetrahydrocannabinol (THC), and others. According to the report, THC represented the largest segment.

Tetrahydrocannabinol (THC) is crucial in propelling the market due to its psychoactive properties and potential therapeutic benefits. As one of the primary cannabinoids found in cannabis, THC is known for its ability to interact with the body's endocannabinoid system, producing various physiological and psychological effects. The psychoactive nature of THC attracts a segment of consumers seeking relief from pain, stress, and anxiety, making it an appealing option for medicinal use. Patients with chronic pain, cancer-related symptoms, and multiple sclerosis may find THC-containing medical cannabis products beneficial in managing their symptoms.

Furthermore, the recreational use of THC has helped destigmatize cannabis overall, leading to increased acceptance and legalization of medical cannabis in various regions. This evolving legal landscape has contributed to the market growth of medical cannabis, making it more accessible to patients in need. As research continues to explore the potential medical applications of THC and its combination with other cannabinoids, the demand for products containing THC is expected to grow, further driving the market expansion.

Breakup by Application:

Cancer

Arthritis

Migraine

Epilepsy

Others

Cancer dominates the market

The report has provided a detailed breakup and analysis of the market based on the application. This includes cancer, arthritis, migraine, epilepsy, and others. According to the report, cancer represented the largest segment.

Cancer is a significant market driver due to its potential to manage cancer-related symptoms and side effects of cancer treatments. Medical cannabis has shown promise in alleviating chemotherapy-induced nausea and vomiting and stimulating appetite in cancer patients experiencing cachexia and weight loss. Moreover, cancer-related pain management is critical for medical cannabis usage, as cannabinoids, including THC and CBD, may offer analgesic properties. Patients seeking alternatives to traditional pain medications are turning to medical cannabis to manage pain and improve their quality of life.

Furthermore, medical cannabis may have anti-inflammatory and anti-tumor properties, sparking interest in its potential role as an adjunct therapy in cancer treatment. Research continues to explore these possibilities, driving the demand for medical cannabis products. The growing number of cancer patients and increasing acceptance of medical cannabis as a complementary treatment option contributes to market growth. As medical professionals recognize the potential benefits, cancer patients are increasingly incorporating medical cannabis into their treatment plans, further fueling the market.

Breakup by End-Use:

Pharmaceutical Industry

Research and Development Centres

Others

Pharmaceutical industry dominates the market

The report has provided a detailed breakup and analysis of the market based on the end-use. This includes the pharmaceutical industry, research and development centres, and others. According to the report, the pharmaceutical industry represented the largest segment.

The pharmaceutical industry is pivotal in strengthening the market through extensive research and development, and commercialization of cannabis-based medications. As the potential therapeutic benefits of cannabinoids and cannabis-derived compounds gain recognition, pharmaceutical companies are investing in clinical trials and R&D activities to develop novel cannabis-based pharmaceutical products. These companies are exploring various delivery methods, formulations, and dosages to create standardized and regulated medical cannabis treatments. By developing pharmaceutical-grade cannabis products, they aim to address concerns about consistency, safety, and efficacy, which are essential for medical professionals and patients.

Furthermore, pharmaceutical companies' involvement in the medical cannabis market brings credibility and legitimacy to the industry, encouraging wider acceptance and adoption by healthcare professionals. This collaboration between the pharmaceutical industry and medical cannabis fosters the integration of cannabis-based treatments into mainstream medicine, driving market growth and expanding the scope of medical cannabis usage for various health conditions.

Breakup by Route of Administration:

Oral Solutions and Capsules

Vaporizers

Topicals

Others

Oral solutions and capsules dominate the market

The report has provided a detailed breakup and analysis of the market based on the route of administration. This includes oral solutions and capsules, vaporizers, topicals and others. According to the report, oral solutions and capsules represented the largest segment.

Oral solutions and capsules are propelling the market due to their convenience, dosage accuracy, and ease of administration. As pharmaceutical companies develop standardized cannabis-based medications in these forms, patients can consume medical cannabis more discreetly and precisely. Oral solutions and capsules offer consistent dosing, making it easier for healthcare professionals to prescribe and monitor patient treatment. This standardization fosters confidence in medical cannabis as a legitimate therapeutic option.

Moreover, these delivery methods cater to patients who prefer a smoke-free and non-inhalation approach to medical cannabis consumption. They especially appeal to older adults and individuals seeking alternative treatments for various health conditions. The convenience of oral solutions and capsules contributes to better patient compliance, leading to more successful treatment outcomes. As medical cannabis gains wider acceptance and pharmaceutical-grade products become available in these forms, the market growth of medical cannabis is accelerated, attracting patients and healthcare professionals to explore its therapeutic potential further.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

Europe

Germany

France

Italy

Spain

Netherlands

Latin America

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest medical cannabis market share

The report has also provided a comprehensive analysis of all the major regional markets, which includes North America (the United States and Canada); Asia Pacific, Europe (Germany, Italy, France, the Netherlands, and Spain), Latin America, and Middle East and Africa. According to the report, North America accounted for the largest market share.

North America is fostering the market growth due to its progressive regulatory environment, increasing acceptance, and widespread legalization across various states and countries in the region. In particular, the United States and Canada have been at the forefront of the medical cannabis movement, with many states and provinces legalizing medical cannabis for therapeutic use. The growing awareness and acceptance of medical cannabis have increased patient demand as individuals seek alternative treatments for various medical conditions. This increasing demand, in turn, has spurred investments in research, development, and commercialization of medical cannabis products, driving market growth.

Moreover, well-established pharmaceutical companies and research institutions in North America have accelerated the development of standardized and regulated cannabis-based medications, further propelling market expansion. The evolving legal landscape, coupled with a strong consumer base and supportive healthcare policies, positions North America as a significant driving force behind the market's global growth.

Competitive Landscape:

Top companies are strengthening the market by leveraging their resources, expertise, and brand recognition. These companies invest heavily in research and development to create innovative cannabis-based products with consistent quality and efficacy. They expand their presence in key markets through strategic partnerships and acquisitions, driving consumer awareness and accessibility. Their established distribution networks enable the widespread availability of medical cannabis products, reaching a broader patient base. Furthermore, these companies also engage in educational initiatives to raise awareness among healthcare professionals and the general public about the therapeutic potential of medical cannabis. Their efforts to comply with regulatory standards and maintain product safety build trust and credibility in the industry. By setting high industry standards and fostering best practices, these companies contribute to the market growth, leading the way for continued expansion and acceptance of medical cannabis as a legitimate and effective treatment option.

The report has provided a comprehensive analysis of the competitive landscape in the medical cannabis market. Detailed profiles of all major companies have also been provided.

Canopy Growth Corporation

GW Pharmaceuticals, plc

Aurora Cannabis, Inc.

Aphria, Inc.

MedReleaf Corporation

Insys Therapeutics, Inc.

CanniMed Therapeutics, Inc.

Cara Therapeutics, Inc.

United Cannabis Corporation

Recent Developments:

In 2020, Canopy Growth entered a strategic partnership with Acreage Holdings, Inc., a U.S.-based cannabis operator. This agreement was structured to allow Canopy Growth to acquire Acreage once cannabis becomes federally legal in the United States. This collaboration aimed to position Canopy Growth for future growth in the U.S. cannabis market.

In 2021, GW Pharmaceuticals was acquired by Jazz Pharmaceuticals. This acquisition allowed Jazz Pharmaceuticals to expand its product portfolio into the cannabinoid-based therapies domain and bolster its presence in the neurology and rare disease markets.

In 2021, Aurora Cannabis completed a strategic business transformation plan involving various cost-saving initiatives, restructuring, and divestitures to improve financial performance and focus on its core businesses.

Key Questions Answered in This Report

• 1. What was the size of the global medical cannabis market in 2023?
• 2. What is the expected growth rate of the global medical cannabis market during 2024-2032?
• 3. What are the key factors driving the global medical cannabis market?
• 4. What has been the impact of COVID-19 on the global medical cannabis market?
• 5. What is the breakup of the global medical cannabis market based on the species?
• 6. What is the breakup of the global medical cannabis market based on the derivatives?
• 7. What is the breakup of the global medical cannabis market based on the application?
• 8. What is the breakup of the global medical cannabis market based on end-use?
• 9. What is the breakup of the global medical cannabis market based on the route of administration?
• 10. What are the key regions in the global medical cannabis market?
• 11. Who are the key players/companies in the global medical cannabis market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Medical Cannabis Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Breakup by Species
• 5.5 Market Breakup by Derivatives
• 5.6 Market Breakup by Application
• 5.7 Market Breakup by End-Use
• 5.8 Market Breakup by Route of Administration
• 5.9 Market Breakup by Region
• 5.10 Market Forecast
• 5.11 SWOT Analysis
  • 5.11.1 Overview
  • 5.11.2 Strengths
  • 5.11.3 Weaknesses
  • 5.11.4 Opportunities
  • 5.11.5 Threats
• 5.12 Value Chain Analysis
  • 5.12.1 Input Suppliers
  • 5.12.2 Collectors
  • 5.12.3 Manufacturers
  • 5.12.4 Distributors
  • 5.12.5 Exporters
  • 5.12.6 Retailers
  • 5.12.7 End-User
• 5.13 Porters Five Forces Analysis
  • 5.13.1 Overview
  • 5.13.2 Bargaining Power of Buyers
  • 5.13.3 Bargaining Power of Suppliers
  • 5.13.4 Degree of Competition
  • 5.13.5 Threat of New Entrants
  • 5.13.6 Threat of Substitutes
• 5.14 Key Success and Risk Factors

6 Market Breakup by Species

• 6.1 Indica
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Sativa
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Hybrid
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast

7 Market Breakup by Derivatives

• 7.1 Cannabidiol (CBD)
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Tetrahydrocannabinol (THC)
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Others
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by Application

• 8.1 Cancer
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Arthritis
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Migraine
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Epilepsy
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Others
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast

9 Market Breakup by End-Use

• 9.1 Pharmaceutical Industry
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Research and Development Centres
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Others
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast

10 Market Breakup by Route of Administration

• 10.1 Oral Solutions and Capsules
  • 10.1.1 Market Trends
  • 10.1.2 Market Forecast
• 10.2 Vaporizers
  • 10.2.1 Market Trends
  • 10.2.2 Market Forecast
• 10.3 Topicals
  • 10.3.1 Market Trends
  • 10.3.2 Market Forecast
• 10.4 Others
  • 10.4.1 Market Trends
  • 10.4.2 Market Forecast

11 Market Breakup by Region

• 11.1 North America
  • 11.1.1 United States
    • 11.1.1.1 Market Trends
    • 11.1.1.2 Market Forecast
  • 11.1.2 Canada
    • 11.1.2.1 Market Trends
    • 11.1.2.2 Market Forecast
• 11.2 Europe
  • 11.2.1 Germany
    • 11.2.1.1 Market Trends
    • 11.2.1.2 Market Forecast
  • 11.2.2 Italy
    • 11.2.2.1 Market Trends
    • 11.2.2.2 Market Forecast
  • 11.2.3 France
    • 11.2.3.1 Market Trends
    • 11.2.3.2 Market Forecast
  • 11.2.4 Netherlands
    • 11.2.4.1 Market Trends
    • 11.2.4.2 Market Forecast
  • 11.2.5 Spain
    • 11.2.5.1 Market Trends
    • 11.2.5.2 Market Forecast
• 11.3 Latin America
  • 11.3.1 Market Trends
  • 11.3.2 Market Forecast
• 11.4 Asia Pacific
  • 11.4.1 Market Trends
  • 11.4.2 Market Forecast
• 11.5 Middle East and Africa
  • 11.5.1 Market Trends
  • 11.5.2 Market Forecast

12 Overview of Clinical Research Suggesting the Benefits of Medical Cannabis Across Various Indications

• 12.1 Alzheimer's Disease
• 12.2 Autism
• 12.3 Cancer
• 12.4 Chronic Pain
• 12.5 Epilepsy
• 12.6 Migraine
• 12.7 Digestive Disorders
• 12.8 Multiple Sclerosis
• 12.9 Schizophrenia
• 12.10 Others

13 Competitive Landscape

• 13.1 Market Structure
• 13.2 Key Players

14 Key Player Profiles

• 14.1 Canopy Growth Corporation
• 14.2 GW Pharmaceuticals, plc
• 14.3 Aurora Cannabis, Inc.
• 14.4 Aphria, Inc.
• 14.5 MedReleaf Corporation
• 14.6 Insys Therapeutics, Inc.
• 14.7 CanniMed Therapeutics, Inc.
• 14.8 Cara Therapeutics, Inc.
• 14.9 United Cannabis Corporation